In the last trading session, 1.59 million Oncolytics Biotech, Inc (NASDAQ:ONCY) shares changed hands as the company’s beta touched 0.94. With the company’s per share price at $0.75 changed hands at $0.03 or 4.25% during last session, the market valuation stood at $66.67M. ONCY’s last price was a discount, traded about -104.0% off its 52-week high of $1.53. The share price had its 52-week low at $0.33, which suggests the last value was 56.0% up since then. When we look at Oncolytics Biotech, Inc’s average trading volume, we note the 10-day average is 1.05 million shares, with the 3-month average coming to 741.36K.
Analysts gave the Oncolytics Biotech, Inc (ONCY) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.40. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended ONCY as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Oncolytics Biotech, Inc (NASDAQ:ONCY) trade information
Instantly ONCY was in green as seen at the end of in last trading. With action 8.77%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -25.68%, with the 5-day performance at 8.77% in the green. However, in the 30-day time frame, Oncolytics Biotech, Inc (NASDAQ:ONCY) is 99.89% up. Looking at the short shares, we see there were 2.61 million shares sold at short interest cover period of 2.09 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 23.13%. The 2025 estimates are for Oncolytics Biotech, Inc earnings to increase by 4.14%, but the outlook for the next 5-year period is at 10.74% per year.
ONCY Dividends
Oncolytics Biotech, Inc is expected to release its next quarterly earnings report on 2025-May-14.
Oncolytics Biotech, Inc (NASDAQ:ONCY)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 3.92% of Oncolytics Biotech, Inc shares while 1.53% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 1.59%. There are 1.53% institutions holding the Oncolytics Biotech, Inc stock share, with INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC the top institutional holder. As of 2024-06-30, the company held 0.2607% of the shares, roughly 0.2 million ONCY shares worth $0.2 million.
SEEDS INVESTOR LLC holds the second largest percentage of outstanding shares, with 0.2496% or 0.19 million shares worth $0.19 million as of 2024-06-30.
With 66.94 shares estimated at $50244.0 under it, the former controlled 0.07% of total outstanding shares.
